← TrialMatch
HomeTrials

Effectiveness of Virtual Reality Therapy in Alcohol Use Disorder Study

Intro: Virtual reality exposure therapy (VRET) has been widely assessed in several mental disorders, including substances use disorders. In the case of alcohol use disorder (AUD), published studies focus mainly on craving interventions: eliciting, triggering, reduction or extinction, with promising result. However, dat

Condition(s)Alcool Use Disorder
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryIntro: Virtual reality exposure therapy (VRET) has been widely assessed in several mental disorders, including substances use disorders. In the case of alcohol use disorder (AUD), published studies focus mainly on craving interventions: eliciting, triggering, reduction or extinction, with promising result. However, data Virtual reality exposure therapy effect on reduction of alcohol consumption or abstinence remains scarce. Hypothesis/Objective: The investigators hypothesis that VRET associated to cognitive behaviors therapy (CBT) will be more effective than CBT alone on the reduction in the cumulative number of standard drinks (vs) of alcohol intakes at 8 months after inclusion. The second objective is the assess its effectiveness on reported craving also at 8 months. Method: The investig
Who can participateInclusion Criteria: * Aged 18 or over, and under 80 on the date of inclusion * Fulfilling Alcohol use disorder according to the DSM-V criteria (American Psychiatric Association, 2013); * In alcohol abstinence for at least 15 days; * Be able to speak, understand and read French; * Signed an informed consent * Affiliated to the French health insurance scheme Exclusion Criteria: * • Major under legal protection measure, or deprived of liberty by judicial or administrative decision; * Pregnant or breastfeeding women; * Decompensated psychiatric disoreder (psychotic disorders, mood disorders and anxiety disorders); * Alcohol use disorder relapse * Severe cognitive impairment as defined by a score of 10 or less at the Montreal Cognitive Assessment (MOCA) (Nasreddine et al., 2005) * Visual impair
Ages18 Years to 80 Years
SexAll
Lead sponsorAssistance Publique - Hôpitaux de Paris
LocationsCréteil, Île-de-France Region, France
Start date2023-11-01
NCT IDNCT06104176
Official listinghttps://clinicaltrials.gov/study/NCT06104176

🔍 Search all trials →